Cargando…
Proteomic Analysis of the Molecular Mechanism of Lovastatin Inhibiting the Growth of Nasopharyngeal Carcinoma Cells
Metabolic abnormalities are one of the essential features of tumors. Increasingly more studies have shown that lovastatin, a lipid-reducing drug, has visible inhibitory effects on tumors, but it has not been reported in nasopharyngeal carcinoma. In this paper, we explored the effects of lovastatin o...
Autores principales: | Mo, Yongzhen, Wang, Yumin, Xiong, Fang, Ge, Xiaolu, Li, Zheng, Li, Xiayu, Li, Yong, Li, Xiaoling, Xiong, Wei, Li, Guiyuan, Zeng, Zhaoyang, Guo, Can |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584415/ https://www.ncbi.nlm.nih.gov/pubmed/31258737 http://dx.doi.org/10.7150/jca.30454 |
Ejemplares similares
-
The emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinoma
por: Fan, Chunmei, et al.
Publicado: (2018) -
Construction of a lncRNA–mRNA Co-Expression Network for Nasopharyngeal Carcinoma
por: Fan, Chunmei, et al.
Publicado: (2022) -
Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2
por: Mo, Yongzhen, et al.
Publicado: (2021) -
GPC6 Promotes Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma
por: Fan, Chunmei, et al.
Publicado: (2019) -
The role of Wnt signaling pathway in tumor metabolic reprogramming
por: Mo, Yongzhen, et al.
Publicado: (2019)